In this hospital-based, case-control study including 317 de novo AML patients and 406 healthy control subjects frequency-matched by age, sex, and ethnicity, we genotyped DNMT3B gene polymorphisms to evaluate the association between this genetic variant and susceptibility to AML. The gene discussed is DNMT3B; the disease is acute myeloid leukemia.